EU Takes Aim at Medicine’s “Male Default” Problem
Turns out medicine has been playing favorites for decades – and spoiler alert, it’s not with women. The European Parliament’s Women’s Rights Committee just voted overwhelmingly (27-9, no fence-sitters) to tackle what they’re calling one of medicine’s “biggest blind spots.”
Here’s the tea: Medical research has basically been designed around male anatomy for ages, which means everything from clinical trials to diagnosis has been giving women the short end of the stethoscope. Heart attacks present differently in women? Who knew! (Well, not the researchers studying only men, apparently.)
The MEPs aren’t pulling punches. They want mandatory gender-sensitive research throughout the entire medical research cycle – yes, including pregnant and breastfeeding women in clinical trials, because shockingly, these humans also need medicine. They’re also side-eyeing artificial intelligence in healthcare, warning it could just copy-paste existing gender and racial biases into fancy new algorithms.
The committee is pushing for binding targets, cold hard cash for women’s health research, and attention to conditions that have been collecting dust in medicine’s “we’ll get to it eventually” pile: endometriosis, menopause symptoms, cardiovascular disease in women, migraines, and mental health conditions.
Irish MEP Billy Kelleher summed it up perfectly: when research fails to reflect women’s experiences, the result is “poorer diagnosis, treatment and care.” Revolutionary concept – studying half the population might improve healthcare for half the population.
The report now heads to a full plenary session, where presumably more people will vote on whether women deserve medical research that actually includes them.